Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TYLAN 100 DIN 02242023

Status: Marketed
Holder: ELANCO CANADA LIMITED
Molecule: TYLOSIN (TYLOSIN PHOSPHATE)

Health Canada record

Active ingredient(s)TYLOSIN (TYLOSIN PHOSPHATE) 220 G
Dosage formDrug Premix
RouteOral
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date15-Aug-2000
Current status date30-Sep-2019
SourceHealth Canada DPD

Establishment licence of the holder

Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TYLOSIN (TYLOSIN PHOSPHATE)

DINProductCompanyFormStrengthStatus
02397846PHARMASIN 100HUVEPHARMA EOODDrug PremixTYLOSIN (TYLOSIN PHOSPHATE) 220 GMarketed
02515385PHARMASIN 40HUVEPHARMA EOODDrug PremixTYLOSIN (TYLOSIN PHOSPHATE) 88 GMarketed
00474444TYLAN 40ELANCO CANADA LIMITEDDrug PremixTYLOSIN (TYLOSIN PHOSPHATE) 88 GMarketed
02472058TYLOSIN 100BIO AGRI MIX LPDrug PremixTYLOSIN (TYLOSIN PHOSPHATE) 220 GMarketed
00800422TYLOSIN 40BIO AGRI MIX LPDrug PremixTYLOSIN (TYLOSIN PHOSPHATE) 88 GMarketed
00103624TYLAN 10ELANCO CANADA LIMITEDDrug PremixTYLOSIN (TYLOSIN PHOSPHATE) 22 GDormant
00637645TYLAN 50/SULFA G PREMIXELANCO DIVISION ELI LILLY CANADA INCDrug PremixTYLOSIN (TYLOSIN PHOSPHATE) 110 G; SULFAMETHAZINE 110 GCancelled Post Market
00713481TYLOSIN 10BIO AGRI MIX LPDrug PremixTYLOSIN (TYLOSIN PHOSPHATE) 22 GDormant

Notices of Compliance

NOCDateSubmissionReason
205402018-03-01New Drug Submission (NDS)MERGER - BUYOUT
204902018-02-15Supplement to a New Drug Submission (SNDS)REMOVAL OF GROWTH PROMOTION CLAIM, CHANGE TO PRESCRIPTION STATUS, LABELLING UPDATES
204902018-02-15Supplement to a New Drug Submission (SNDS)REMOVAL OF GROWTH PROMOTION CLAIM, CHANGE TO PRESCRIPTION STATUS, LABELLING UPDATES
135442012-08-08Supplement to a New Drug Submission (SNDS)Manufacturing Changes
107372009-11-02Supplement to a New Drug Submission (SNDS)Additional swine indication
90822007-10-12Supplement to a New Drug Submission (SNDS)NEW INDICATIONS: (1) AS AN AID IN THE TREATMENT OF NECROTIC ENTERITIS CAUSED BY CLOSTRIDIUM PERFRINGENS IN BROILER CHICKENS (2) AS AN AID IN THE TREATMENT OF PROCINE PROLIFERATIVE ENTEROPATHY (PPE) OR ILEITIS ASSOCIATED WITH LAWSONIA INTRACELLULARIS WHEN USED FOLLOWING TREATMENT WITH ELANCO TYLAN SOLUBLE
65242000-04-06New Drug Submission (NDS)
Request a quote for TYLAN 100

How to read a Canadian DIN record